CN101910168B - 托烷化合物 - Google Patents
托烷化合物 Download PDFInfo
- Publication number
- CN101910168B CN101910168B CN200880122860.5A CN200880122860A CN101910168B CN 101910168 B CN101910168 B CN 101910168B CN 200880122860 A CN200880122860 A CN 200880122860A CN 101910168 B CN101910168 B CN 101910168B
- Authority
- CN
- China
- Prior art keywords
- amino
- bridge
- azabicyclo
- oct
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *C(CC1C23C1)CC2N3c(cc1)ncc1C(N)=O Chemical compound *C(CC1C23C1)CC2N3c(cc1)ncc1C(N)=O 0.000 description 19
- CDVMWTAGTIOTOR-UHFFFAOYSA-N Cc1c2[o]ccc2ccc1C(O)=O Chemical compound Cc1c2[o]ccc2ccc1C(O)=O CDVMWTAGTIOTOR-UHFFFAOYSA-N 0.000 description 2
- DIPOKNKRBVPHTA-UHFFFAOYSA-N Bc(cc1C(N)=O)c(C)cc1NCCC Chemical compound Bc(cc1C(N)=O)c(C)cc1NCCC DIPOKNKRBVPHTA-UHFFFAOYSA-N 0.000 description 1
- ARTSKENQKZVRQU-UHFFFAOYSA-N CC(C)(C)OC(NC(CC1CC2)CC2N1c(cc1)ncc1C(O)=O)=O Chemical compound CC(C)(C)OC(NC(CC1CC2)CC2N1c(cc1)ncc1C(O)=O)=O ARTSKENQKZVRQU-UHFFFAOYSA-N 0.000 description 1
- YWZGKSDIXLVLPQ-UHFFFAOYSA-N CC(C)C(C)Nc1cc(C(O)=O)ccc1C(N)=O Chemical compound CC(C)C(C)Nc1cc(C(O)=O)ccc1C(N)=O YWZGKSDIXLVLPQ-UHFFFAOYSA-N 0.000 description 1
- FSGHCFYJAFYQJH-UHFFFAOYSA-N CC(C1CC1)Nc(c(Cl)c(cc1)C(O)=O)c1C(N)=O Chemical compound CC(C1CC1)Nc(c(Cl)c(cc1)C(O)=O)c1C(N)=O FSGHCFYJAFYQJH-UHFFFAOYSA-N 0.000 description 1
- HUNANSGNFJZUFZ-UHFFFAOYSA-N CC(Nc1cc(C(O)=O)ccc1C(N)=O)=O Chemical compound CC(Nc1cc(C(O)=O)ccc1C(N)=O)=O HUNANSGNFJZUFZ-UHFFFAOYSA-N 0.000 description 1
- AXANILHPMDKJAD-UHFFFAOYSA-N CC(c(cc1)cnc1N(C(CC1)C2)C1C2N)=O Chemical compound CC(c(cc1)cnc1N(C(CC1)C2)C1C2N)=O AXANILHPMDKJAD-UHFFFAOYSA-N 0.000 description 1
- BSEJJGIQRPYMTF-UHFFFAOYSA-N CCC(CC)Nc(c(C([NH+]=[I-])=O)c1)cc(C(O)=O)c1F Chemical compound CCC(CC)Nc(c(C([NH+]=[I-])=O)c1)cc(C(O)=O)c1F BSEJJGIQRPYMTF-UHFFFAOYSA-N 0.000 description 1
- LKDNFZJQCLJKJH-UHFFFAOYSA-N CCCNc1cc(C(O)=O)c(C)cc1C(N)=O Chemical compound CCCNc1cc(C(O)=O)c(C)cc1C(N)=O LKDNFZJQCLJKJH-UHFFFAOYSA-N 0.000 description 1
- ACBBSXGOMIJTKZ-UHFFFAOYSA-N CCOC(NC=C)N(C(C1)C2)C1CC2N Chemical compound CCOC(NC=C)N(C(C1)C2)C1CC2N ACBBSXGOMIJTKZ-UHFFFAOYSA-N 0.000 description 1
- HLNZTFOUCOSCEN-UHFFFAOYSA-N CCOC(c(cc1)cnc1N(C(CC1)C2)C1CC2N)=O Chemical compound CCOC(c(cc1)cnc1N(C(CC1)C2)C1CC2N)=O HLNZTFOUCOSCEN-UHFFFAOYSA-N 0.000 description 1
- GWCIZIVZCVPVAY-ZCFIWIBFSA-N CC[C@@H](C)Nc1cc(C(O)=O)c(C(F)(F)F)cc1C(N)=O Chemical compound CC[C@@H](C)Nc1cc(C(O)=O)c(C(F)(F)F)cc1C(N)=O GWCIZIVZCVPVAY-ZCFIWIBFSA-N 0.000 description 1
- SBLXNKYXBHQRBT-SECBINFHSA-N CC[C@@H](C)Nc1cc(C(O)=O)c(CC)cc1C([NH+](C)[NH-])=O Chemical compound CC[C@@H](C)Nc1cc(C(O)=O)c(CC)cc1C([NH+](C)[NH-])=O SBLXNKYXBHQRBT-SECBINFHSA-N 0.000 description 1
- NVOBZOBFMIXVEZ-MRVPVSSYSA-N CC[C@@H](C)Nc1cc(C(O)=O)ccc1C(NC)=O Chemical compound CC[C@@H](C)Nc1cc(C(O)=O)ccc1C(NC)=O NVOBZOBFMIXVEZ-MRVPVSSYSA-N 0.000 description 1
- OYSGMQNCQROVAV-UHFFFAOYSA-N CN(C)CCOc1cc(Nc2cc(C(O)=O)ccc2C(N)=O)ccc1OC Chemical compound CN(C)CCOc1cc(Nc2cc(C(O)=O)ccc2C(N)=O)ccc1OC OYSGMQNCQROVAV-UHFFFAOYSA-N 0.000 description 1
- VGYLMOJQAHXYCK-UHFFFAOYSA-N CN1CNCC1 Chemical compound CN1CNCC1 VGYLMOJQAHXYCK-UHFFFAOYSA-N 0.000 description 1
- MOFSNGOPOQLJHA-NKPUCLBHSA-N C[C@@H](C1C=CC(N2CCN(C)CC2)=CC1)NC(c(cc1)cnc1N(C(C1)C2)C1C2NC(OC(C)(C)C)=O)=O Chemical compound C[C@@H](C1C=CC(N2CCN(C)CC2)=CC1)NC(c(cc1)cnc1N(C(C1)C2)C1C2NC(OC(C)(C)C)=O)=O MOFSNGOPOQLJHA-NKPUCLBHSA-N 0.000 description 1
- LGEPNRWKNPFLJQ-UHFFFAOYSA-N Cc(cc(cc1)C(N)=O)c1C(O)=O Chemical compound Cc(cc(cc1)C(N)=O)c1C(O)=O LGEPNRWKNPFLJQ-UHFFFAOYSA-N 0.000 description 1
- PBCOFAPBDVQUQZ-UHFFFAOYSA-N Cc1c2[o]ccc2ccc1C(NC(CC1CC2)CC2N1c(cc1)ncc1C(O)=O)=O Chemical compound Cc1c2[o]ccc2ccc1C(NC(CC1CC2)CC2N1c(cc1)ncc1C(O)=O)=O PBCOFAPBDVQUQZ-UHFFFAOYSA-N 0.000 description 1
- OVJWYQZAYRNOAO-UHFFFAOYSA-N Cc1c[o]c2c(C)c(C(NC(CC3CC4)C4N3c(cc3)ncc3C(N)=O)=O)ccc12 Chemical compound Cc1c[o]c2c(C)c(C(NC(CC3CC4)C4N3c(cc3)ncc3C(N)=O)=O)ccc12 OVJWYQZAYRNOAO-UHFFFAOYSA-N 0.000 description 1
- SBHJKGCZZULRSN-UHFFFAOYSA-N ICC(COC12)C1OCC21OCCO1 Chemical compound ICC(COC12)C1OCC21OCCO1 SBHJKGCZZULRSN-UHFFFAOYSA-N 0.000 description 1
- BXWSTEKVTTZMIC-UHFFFAOYSA-N NC(c(c(N1CCC1)c1)ccc1C(O)=O)=O Chemical compound NC(c(c(N1CCC1)c1)ccc1C(O)=O)=O BXWSTEKVTTZMIC-UHFFFAOYSA-N 0.000 description 1
- LDNDDJQPPUFINN-UHFFFAOYSA-O [NH3+]C(c1ccc(C(O)=O)c2c1[nH]cc2)=O Chemical compound [NH3+]C(c1ccc(C(O)=O)c2c1[nH]cc2)=O LDNDDJQPPUFINN-UHFFFAOYSA-O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68707P | 2007-10-25 | 2007-10-25 | |
| US61/000,687 | 2007-10-25 | ||
| PCT/US2008/012221 WO2009055077A1 (en) | 2007-10-25 | 2008-10-27 | Tropane compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101910168A CN101910168A (zh) | 2010-12-08 |
| CN101910168B true CN101910168B (zh) | 2014-07-30 |
Family
ID=40287869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200880122860.5A Expired - Fee Related CN101910168B (zh) | 2007-10-25 | 2008-10-27 | 托烷化合物 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8012956B2 (enExample) |
| EP (1) | EP2074120B1 (enExample) |
| JP (2) | JP5476307B2 (enExample) |
| KR (1) | KR101578792B1 (enExample) |
| CN (1) | CN101910168B (enExample) |
| AT (1) | ATE459622T1 (enExample) |
| AU (1) | AU2008317262B2 (enExample) |
| BR (1) | BRPI0818893B8 (enExample) |
| CA (1) | CA2703477C (enExample) |
| CO (1) | CO6321232A2 (enExample) |
| CY (1) | CY1110648T1 (enExample) |
| DE (1) | DE602008000754D1 (enExample) |
| DK (1) | DK2074120T3 (enExample) |
| EA (1) | EA018999B1 (enExample) |
| ES (1) | ES2342348T3 (enExample) |
| HR (1) | HRP20100292T1 (enExample) |
| IL (1) | IL205202A0 (enExample) |
| MX (1) | MX2010004493A (enExample) |
| NZ (1) | NZ585137A (enExample) |
| PL (1) | PL2074120T3 (enExample) |
| PT (1) | PT2074120E (enExample) |
| RS (1) | RS51346B (enExample) |
| SG (1) | SG2012079653A (enExample) |
| SI (1) | SI2074120T1 (enExample) |
| WO (1) | WO2009055077A1 (enExample) |
| ZA (1) | ZA201002987B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2231666B1 (en) * | 2007-12-12 | 2015-07-29 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| UY32940A (es) | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
| RU2012146986A (ru) | 2010-04-05 | 2014-05-20 | Сионоги Энд Ко., Лтд. | Цефемовые соединения, содержащие катехольную группу |
| EP2640366A2 (en) | 2010-11-15 | 2013-09-25 | Exelixis, Inc. | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture |
| EP2740474A1 (en) | 2012-12-05 | 2014-06-11 | Instituto Europeo di Oncologia S.r.l. | Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a |
| US20150352086A1 (en) * | 2013-01-07 | 2015-12-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Heat shock protein (hsp) inhibition and monitoring effectiveness thereof |
| MX2016002199A (es) | 2013-08-21 | 2016-07-13 | Alios Biopharma Inc | Compuestos antivirales. |
| AU2014348232A1 (en) * | 2013-11-18 | 2016-06-30 | Del Mar Pharmaceuticals | HPLC analysis of impurities in dianhydrogalactitol |
| EP2949648A1 (en) | 2014-05-30 | 2015-12-02 | IEO - Istituto Europeo di Oncologia Srl | Cyclopropylamine derivatives as histone demethylase inhibitors |
| JP6320570B2 (ja) | 2014-05-30 | 2018-05-09 | イエオ−イスティトゥート・エウロペオ・ディ・オンコロジア・エッセ・エッレ・エッレ | ヒストンデメチラーゼ阻害剤としてのシクロプロピルアミン化合物 |
| TW201625243A (zh) | 2014-10-14 | 2016-07-16 | 艾克塞里克斯公司 | 用於治療黑素瘤之藥物組合 |
| CN108136055A (zh) * | 2015-07-16 | 2018-06-08 | 阿库鲁制药公司 | 用连接有标记、细胞毒或免疫调节基团的slc6a3配体检测与治疗肾细胞癌 |
| EP3588064B1 (en) * | 2017-02-23 | 2022-09-07 | IHI Corporation | Oh radical detection probe, oh radical measurement device, and oh radical measurement method |
| CN108164529B (zh) * | 2017-12-25 | 2020-04-24 | 三峡大学 | 一种小分子抑制剂sld9059及其在制药中的应用 |
| US11466012B2 (en) | 2018-01-10 | 2022-10-11 | Allinky Biopharma | Tetrahydroisoquinoline compounds |
| CN111825702A (zh) * | 2019-04-22 | 2020-10-27 | 成都科岭源医药技术有限公司 | 一种氮杂*并吲唑类衍生物及其制备方法和用途 |
| CN110698395B (zh) * | 2019-10-22 | 2021-05-25 | 杭州百诚医药科技股份有限公司 | 一种托吡司特的中间体的制备方法 |
| CN112920078A (zh) * | 2019-12-05 | 2021-06-08 | 武汉珈汇精化科技有限公司 | 一种制备4-氰基苯甲酸甲酯的方法和一种制备4-氰基苯甲酸的方法 |
| TW202136238A (zh) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | RORγt抑制劑及其製備方法和用途 |
| CN116615422A (zh) * | 2020-10-14 | 2023-08-18 | 珃诺生物医药科技(杭州)有限公司 | 用于靶向蛋白降解的方法和组合物 |
| CN114591192B (zh) * | 2020-12-04 | 2024-06-21 | 江西仰立新材料有限公司 | 一种n-环丙甲基苯胺类化合物的制备方法 |
| US20240083910A1 (en) * | 2020-12-18 | 2024-03-14 | Merck Sharp & Dohme Llc | Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses |
| CN112707809B (zh) * | 2020-12-30 | 2023-08-29 | 丽珠集团新北江制药股份有限公司 | 一种制备噁唑啉杀虫剂氟雷拉纳中间体的方法 |
| CA3226271A1 (en) | 2021-07-26 | 2023-02-02 | Zoetis Services Llc | Serotonin 5-ht2b inhibitory compounds |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1798745A (zh) * | 2003-06-24 | 2006-07-05 | 神经研究公司 | 新颖的8－氮杂双环[3.2.1]辛烷衍生物及它们作为单胺神经递质再摄取抑制剂的用途 |
| CN1863801A (zh) * | 2003-10-03 | 2006-11-15 | 辉瑞大药厂 | 具有ccr5受体拮抗剂活性的用于治疗hiv和炎症的被咪唑并吡啶取代的托烷衍生物 |
| CN101010320A (zh) * | 2004-07-29 | 2007-08-01 | 赛诺菲-安万特 | 氨基托烷衍生物及其制备方法和治疗用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0101641A3 (en) | 1982-07-22 | 1984-03-28 | Beecham Group Plc | Sulfonylamino-aza-bicyclo-alkyl derivatives |
| FR2738569B1 (fr) | 1995-09-12 | 1997-11-28 | Pf Medicament | Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique |
| CN1104430C (zh) | 1996-01-15 | 2003-04-02 | 詹森药业有限公司 | 抑制血管生成的哒嗪胺 |
| HUP0202001A2 (hu) * | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok |
| EP1626970B1 (en) | 2003-05-28 | 2009-07-08 | Theravance, Inc. | Azabicycloalkane compounds as muscarinic receptor antagonists |
| EA009941B1 (ru) * | 2003-10-03 | 2008-04-28 | Пфайзер Инк. | Имидазопиридинзамещённые тропановые производные, обладающие активностью антагониста ccr5 рецептора, для лечения вируса иммунодефицита человека (вич) и воспаления |
| CN1938292B (zh) * | 2004-03-31 | 2011-10-05 | 日本曹达株式会社 | 环胺化合物和有害生物防除剂 |
| US7713990B2 (en) | 2005-01-13 | 2010-05-11 | Neurosearch A/S | 3,8-substituted 8-AZA-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors |
| CN102127078A (zh) * | 2005-07-14 | 2011-07-20 | 安斯泰来制药株式会社 | Janus激酶3的杂环类抑制剂 |
| EA014057B1 (ru) * | 2005-10-06 | 2010-08-30 | Ниппон Сода Ко., Лтд. | Поперечно связанные соединения циклических аминов и средства для борьбы с вредителями |
| CN101511818B (zh) * | 2006-09-01 | 2013-05-08 | 大塚农业科技株式会社 | N-吡啶基哌啶化合物、其制备方法及有害生物防治剂 |
-
2008
- 2008-10-27 CN CN200880122860.5A patent/CN101910168B/zh not_active Expired - Fee Related
- 2008-10-27 WO PCT/US2008/012221 patent/WO2009055077A1/en not_active Ceased
- 2008-10-27 BR BRPI0818893A patent/BRPI0818893B8/pt not_active IP Right Cessation
- 2008-10-27 JP JP2010531069A patent/JP5476307B2/ja not_active Expired - Fee Related
- 2008-10-27 PL PL08832769T patent/PL2074120T3/pl unknown
- 2008-10-27 AU AU2008317262A patent/AU2008317262B2/en not_active Ceased
- 2008-10-27 AT AT08832769T patent/ATE459622T1/de active
- 2008-10-27 HR HR20100292T patent/HRP20100292T1/hr unknown
- 2008-10-27 CA CA2703477A patent/CA2703477C/en active Active
- 2008-10-27 EP EP08832769A patent/EP2074120B1/en active Active
- 2008-10-27 ES ES08832769T patent/ES2342348T3/es active Active
- 2008-10-27 DK DK08832769.7T patent/DK2074120T3/da active
- 2008-10-27 KR KR1020107011444A patent/KR101578792B1/ko not_active Expired - Fee Related
- 2008-10-27 MX MX2010004493A patent/MX2010004493A/es active IP Right Grant
- 2008-10-27 RS RSP-2010/0220A patent/RS51346B/sr unknown
- 2008-10-27 SG SG2012079653A patent/SG2012079653A/en unknown
- 2008-10-27 NZ NZ585137A patent/NZ585137A/en not_active IP Right Cessation
- 2008-10-27 US US12/290,159 patent/US8012956B2/en active Active
- 2008-10-27 DE DE602008000754T patent/DE602008000754D1/de active Active
- 2008-10-27 PT PT08832769T patent/PT2074120E/pt unknown
- 2008-10-27 SI SI200830024T patent/SI2074120T1/sl unknown
- 2008-10-27 EA EA201070519A patent/EA018999B1/ru not_active IP Right Cessation
-
2010
- 2010-04-19 IL IL205202A patent/IL205202A0/en active IP Right Grant
- 2010-04-29 ZA ZA2010/02987A patent/ZA201002987B/en unknown
- 2010-05-24 CO CO10061824A patent/CO6321232A2/es not_active Application Discontinuation
- 2010-06-01 CY CY20101100483T patent/CY1110648T1/el unknown
-
2013
- 2013-12-13 JP JP2013257559A patent/JP5745021B2/ja not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1798745A (zh) * | 2003-06-24 | 2006-07-05 | 神经研究公司 | 新颖的8－氮杂双环[3.2.1]辛烷衍生物及它们作为单胺神经递质再摄取抑制剂的用途 |
| CN1863801A (zh) * | 2003-10-03 | 2006-11-15 | 辉瑞大药厂 | 具有ccr5受体拮抗剂活性的用于治疗hiv和炎症的被咪唑并吡啶取代的托烷衍生物 |
| CN101010320A (zh) * | 2004-07-29 | 2007-08-01 | 赛诺菲-安万特 | 氨基托烷衍生物及其制备方法和治疗用途 |
Non-Patent Citations (1)
| Title |
|---|
| Barril X,et al..4-amino derivatives of the Hsp90 inhibitor CCT018159.《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》.2006,第16卷(第9期),第2543-2548页. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101910168B (zh) | 托烷化合物 | |
| JP6728208B2 (ja) | ベンザゼピンジカルボキサミド化合物 | |
| JP6938628B2 (ja) | 造血器型プロスタグランジンｄシンターゼ阻害剤としての１，３二置換シクロブタンまたはアゼチジン誘導体 | |
| JP6882299B2 (ja) | 多環式ｔｌｒ７／８アンタゴニスト及び免疫障害の治療におけるそれらの使用 | |
| US8440663B2 (en) | 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use | |
| EP2772490B1 (en) | Aminoalkyl-substituted n-thienyl benzamide derivative | |
| US9562035B2 (en) | Benzamide derivative useful as FASN inhibitors for the treatment of cancer | |
| AU2016293446A1 (en) | Substituted aza compounds as IRAK-4 inhibitors | |
| WO2011088192A1 (en) | Compounds and methods | |
| JP2005537247A (ja) | 置換されたキノリンｃｃｒ５受容体アンタゴニスト | |
| TW202342458A (zh) | Ｐａｒｇ抑制劑 | |
| WO2006067445A2 (en) | Csf-1r kinase inhibitors | |
| JP2013517283A (ja) | 電位依存性ナトリウムチャネル遮断薬 | |
| US20240400591A1 (en) | Compounds targeting mutant of p53 | |
| TW202235072A (zh) | 用於治療ｔｒｐｍ３介導病症之雜環衍生物 | |
| AU2014234909A1 (en) | Acyclic cyanoethylpyrazolo pyridones as Janus kinase inhibitors | |
| CN116761796A (zh) | 用于治疗trpm3介导的病症的芳基衍生物 | |
| HK1129390B (en) | Tropane compounds | |
| TW202430512A (zh) | 類木瓜蛋白酶(PLpro)抑制劑 | |
| HK1129043A (en) | Pyridine and pyrazine derivatives as mnk kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140730 |